Hsbc Holdings PLC Fulgent Genetics, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 74,559 shares of FLGT stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,559

Previous 75,686 1.49%

Holding current value

$1.37 Million

Previous $1.48 Million 9.1%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.6 - $25.06 $22,089 - $28,242	-1,127 Reduced 1.49%	74,559 $1.62 Million
Q2 2024 Aug 12, 2024	SELL	$19.09 - $22.57 $1,240 - $1,467	-65 Reduced 0.09%	75,686 $1.48 Million
Q1 2024 May 15, 2024	BUY	$21.55 - $29.29 $1.29 Million - $1.75 Million	59,802 Added 374.96%	75,751 $1.64 Million
Q4 2023 Feb 12, 2024	BUY	$23.64 - $30.27 $67,704 - $86,693	2,864 Added 21.89%	15,949 $461,000
Q3 2023 Nov 13, 2023	BUY	$26.74 - $40.81 $349,892 - $533,998	13,085 New	13,085 $349,000
Q2 2022 Aug 11, 2022	SELL	$47.98 - $62.75 $22,166 - $28,990	-462 Reduced 8.17%	5,190 $285,000
Q1 2022 May 16, 2022	BUY	$49.85 - $96.11 $91,375 - $176,169	1,833 Added 48.0%	5,652 $350,000
Q4 2021 Feb 11, 2022	SELL	$77.3 - $105.0 $340,661 - $462,735	-4,407 Reduced 53.57%	3,819 $384,000
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $59,521 - $88,141	-795 Reduced 8.81%	8,226 $751,000
Q2 2021 Aug 13, 2021	SELL	$66.8 - $100.45 $628,988 - $945,837	-9,416 Reduced 51.07%	9,021 $832,000
Q1 2021 May 14, 2021	BUY	$59.3 - $183.85 $1.09 Million - $3.39 Million	18,437 New	18,437 $1.78 Million

Others Institutions Holding FLGT

# of Institutions

200

Shares Held

16M

Call Options Held

2.04M

Put Options Held

14K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $555M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Fulgent Genetics, Inc. Transaction History